SynerFuse

The National Due Diligence Alliance (TNDDA) provides a forum for independent broker/dealers, family offices, and advisors, product and service sponsors, law firms, and analysts to facilitate the due diligence process for the benefit of the investing public. Chief Medical Officer Dr. Rohan Lall and CEO Justin Zenanko gave a 25-minute presentation on SynerFuse at the Alliance's conference, held in Houston, Texas, November 22-24, and had conversations with attendees who visited the company’s exhibit booth. #neuromodulation #spinalfusion #painmanagement #opioidcrisis #chronicpain #neurostimulation #medicaldevices #medtech #medicaldevice #healthcare #health #researchandinnovation #research #innovation #backpain Steven Falowski - Chris Frank - David Miel - Brooke Campbell - Nameer Haider - Thomas S., Schreier, Jr. - Dennis McFadden - Barbara S. - Jeff Erb

The following contains information regarding an investigational product, the safety or effectiveness of which has not been established. This investigational product is not approved by the FDA and is currently being studied under an FDA-approved Investigational Device Exemption study. The product is limited by Federal (U.S.) law to investigational use only. SynerFuse? makes no claims of safety or effectiveness of the investigational product, and the intent of presenting this information is to convey research and development initiatives underway at SynerFuse?. Check out Episode 280 of The Back Doctors podcast in which host Dr. Michael Johnson and SynerFuse? President & CEO Justin Zenanko discuss our patented Electric Transforaminal Lumbar Interbody Fusion (e-TLIF?), https://lnkd.in/g9WqUJj7 #neuromodulation #spinalfusion #painmanagement #opioidcrisis #chronicpain #neurostimulation #medicaldevices #medtech #medicaldevice #healthcare #health #researchandinnovation #research #innovation #backpain Steven Falowski - Rohan Lall - Chris Frank - David Miel - Brooke Campbell - Nameer Haider - Thomas S., Schreier, Jr. - Dennis McFadden - Barbara S. - Jeff Erb

Now presenting at #InnovationSanDiego is SynerFuse with CEO & Co-founder Justin Zenanko. The patented SynerFuse? (Eden Prairie, Minnesota, USA) procedure, Electric Transforaminal Lumbar Interbody Fusion (e-TLIF?), combines fusion with direct nerve stimulation to address chronic low back and leg pain that is unaddressed in traditional spinal fusion surgery. The aims of SynerFuse is to decrease number of back fusions/surgeries related to pain and address chronic pain at the point of surgery. Remain informed on new articles, conference updates and more with our helpful #medtech community newsletter. Subscribe here: https://bit.ly/42KHJKI

ICYMI: Check out this recent Bionics Institute podcast featuring SynerFuse CEO Justin Zenanko...

The following contains information regarding an investigational product, the safety or effectiveness of which has not been established. This investigational product is not approved by the FDA and is currently being studied under an FDA-approved Investigational Device Exemption study. The product is limited by Federal (U.S.) law to investigational use only. SynerFuse? makes no claims of safety or effectiveness of the investigational product, and the intent of presenting this information is to convey research and development initiatives underway at SynerFuse?. Check out this new Bionics Institute Med Tech Talks podcast episode in which Robert Klupacs is joined by Justin Zenanko, co-founder, CEO and president of SynerFuse?. In this episode you will hear about: -The global need to address opioid dependency by developing innovative drug-free treatments for chronic pain -How the SynerFuse e-TLIF technology stimulates the dorsal root ganglion as part of spinal fusion surgery – a world-first approach -How Justin and his co-founders overcame skepticism from specialists and the challenges of the COVID pandemic to get FDA approval on a feasibility study -Why Justin has invested his own money into SynerFuse and his advice to other unconventional entrepreneurs. Listen here: https://lnkd.in/gZpJxsFj #MedTech #HealthcareInnovation #ChronicPain #OpioidCrisis #Neuromodulation #PainManagement #SpinalFusion #Entrepreneur #BackPain

The following contains information regarding an investigational product, the safety or effectiveness of which has not been established. This investigational product is not approved by the FDA and is currently being studied under an FDA-approved Investigational Device Exemption study. The product is limited by Federal (U.S.) law to investigational use only. SynerFuse? makes no claims of safety or effectiveness of the investigational product, and the intent of presenting this information is to convey research and development initiatives underway at SynerFuse?. CEO & Co-Founder Justin Zenanko recently presented on SynerFuse at the KCD Annual Conference in Milwaukee—an event focused on professional development and growth strategies in wealth management. #neuromodulation #spinalfusion #painmanagement #opioidcrisis #chronicpain #neurostimulation #medicaldevices #medtech #medicaldevice #healthcare #health #researchandinnovation #research #innovation #backpain #wealthmanagement #growthstrategies Steven Falowski - Rohan Lall - Chris Frank - David Miel - Brooke Campbell - Nameer Haider - Thomas S., Schreier, Jr. - Dennis McFadden - Barbara S. - Arti Masturzo MD MBA - Jeff Erb

SynerFuse CEO & Co-Founder Justin Zenanko recently discussed the company in a presentation to the Family Office Club in New York City. #neuromodulation #spinalfusion #painmanagement #opioidcrisis #chronicpain #neurostimulation #medicaldevices #medtech #medicaldevice #healthcare #health #researchandinnovation #research #innovation #backpain Steven Falowski - Rohan Lall - Chris Frank - David Miel - Brooke Campbell - Nameer Haider - Thomas S., Schreier, Jr. - Dennis McFadden - Barbara S. - Arti Masturzo MD MBA - Jeff Erb

News Alert The following contains information regarding an investigational product, the safety or effectiveness of which has not been established. This investigational product is not approved by the FDA and is currently being studied under an FDA-approved Investigational Device Exemption study. The product is limited by Federal (U.S.) law to investigational use only. SynerFuse? makes no claims of safety or effectiveness of the investigational product, and the intent of presenting this information is to convey research and development initiatives underway at SynerFuse?. WDIO TV in Duluth reports, "A Duluthian man went from barely able to walk to now moving around pain free thanks to this new innovative medical technology. SynerFuse is a company made of specialists from the University of Minnesota and the Fairview Health system. They are working towards better and more regular outcomes with spine surgeries." Watch and read WDIO's full report here: https://lnkd.in/grVdfE9J #neuromodulation #spinalfusion #painmanagement #opioidcrisis #chronicpain #neurostimulation #medicaldevices #medtech #medicaldevice #healthcare #health #researchandinnovation #research #innovation #backpain Justin Zenanko - Steven Falowski - Rohan Lall - Chris Frank - David Miel - Brooke Campbell - Nameer Haider - Thomas S., Schreier, Jr. - Dennis McFadden - Barbara S. - Arti Masturzo MD MBA - Jeff Erb

The following contains information regarding an investigational product, the safety or effectiveness of which has not been established. This investigational product is not approved by the FDA and is currently being studied under an FDA-approved Investigational Device Exemption study. The product is limited by Federal (U.S.) law to investigational use only. SynerFuse? makes no claims of safety or effectiveness of the investigational product, and the intent of presenting this information is to convey research and development initiatives underway at SynerFuse?. Check out this episode of The Deal Scout podcast in which host?Joshua Wilson converses?with SynerFuse CEO Justin Zenanko, "a remarkable guest whose journey from a certified public accountant (CPA) to a key player in the medical device industry is nothing short of inspiring...?[His] transition from a CPA to raising capital for groundbreaking medical technologies is a testament to the power of adaptability and passion." Watch or listen here: https://lnkd.in/gYKiCtYk #neuromodulation #spinalfusion #painmanagement #opioidcrisis #chronicpain #neurostimulation #medicaldevices #medtech #medicaldevice #healthcare #health #researchandinnovation #research #innovation #business #businessdevelopment Steven Falowski - Rohan Lall - Chris Frank - David Miel - Brooke Campbell - Nameer Haider - Thomas S., Schreier, Jr. - Dennis McFadden - Barbara S. - Arti Masturzo MD MBA - Jeff Erb

Thank you to ?? Kip Knippel - Headhunter Recruiter ??for showcasing SynerFuse! Check it out...